The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders

Transfusion

Volumn 46, Issue 8, 2006, Pages 1360-1366

  Posthouwer, Dirk ^a   Fischer, Kathelijn ^b   Van Erpecum, Karel J ^b   Mauser Bunschoten, Eveline P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING DISORDER; CHILDHOOD; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; SCHOOL CHILD; STATISTICAL ANALYSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; CHILD; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT; LIVER CIRRHOSIS; MALE; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES;

EID: 33746325132     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00903.x     Document Type: Article

References (39)

1. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983;287:1754-7.
2. Kernoff PB, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985;60:469-79.
3. Mauser-Bunschoten EP, Bresters D, van Drimmelen AA, et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995;45:241-6.
4. Soucie JM, Richardson LC, Evatt BL, et al. Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males. Transfusion 2001;41:338-43.
5. Franchini M, Rossetti G, Tagliaferri A, et al. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001;98:1836-41.
6. Goedert JJ, Eyster ME, Lederman MM, et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002;100:1584-9.
7. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000;47:845-51.
8. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004;39:90-6.
9. Garcia-Monzon C, Jara P, Fernandez-Bermejo M, et al. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology 1998;28:1696-701.
10. Guido M, Rugge M, Jara P, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998;115:1525-9.
11. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997;90:4628-33.
12. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866-70.
13. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
14. Castellino S, Lensing S, Riely C, et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 2004;103:2460-6.
15. Zellos A, Thomas DL, Mocilnikar C, et al. High viral load and mild liver injury in children with hemophilia compared with other children with chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr 1999;29:418-23.
16. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36:S35-S46.
17. van der Poel CL, Reesink HW, Mauser-Bunschoten EP, et al. Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in the Netherlands. Vox Sang 1991;61:30-6.
18. Guo ZP, Yu MW. Hepatitis C virus RNA in factor VIII concentrates. Transfusion 1995;35:112-6.
19. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002;21:1023-32.
20. Richter J, de Bernardis C, Sagir A, et al. Is ultrasound a useful adjunct for assessing malaria patients? Parasitol Res 2004;94:349-53.
21. Tarantino L, Giorgio A, de Stefano G, et al. Disseminated mycobacterial infection in AIDS patients: abdominal US features and value of fine-needle aspiration biopsy of lymph nodes and spleen. Abdom Imaging 2003;28:602-8.
22. Plug I, van der Bom JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-6.
23. Eyster ME, Sanders J, Goedert JJ. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia. Haemophilia 2004;10:75-80.
24. Piasecki BA, Lewis JD, Reddy KR, et al. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 2004;40:892-9.
25. Spada E, Mele A, Berton A, et al. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 2004;53:1673-81.
26. Messick K, Sanders JC, Goedert JJ, Eyster ME. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia 2001;7:568-74.
27. Quinn PG, Jamal MM, Carey JD, et al. A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia. Am J Gastroenterol 1999;94:668-73.
28. Posthouwer D, Wolters VM, Fischer K, et al. Hepatitis C infection in children with haemophilia: a pilot study. Haemophilia 2004;10:722-6.
29. Tovo PA, Pembrey LJ, Newell ML. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J Infect Dis 2000;181:419-24.
30. Jonas MM. Children with hepatitis C. Hepatology 2002;36:S173-S178.
31. Locasciulli A, Testa M, Valsecchi MG, et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 1997;90:3799-805.
32. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-82.
33. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001;33:455-63.
34. Shin JL, Teitel J, Swain MG, et al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C. is it safe and useful? Am J Hematol 2005;78:85-93.
35. Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92.
36. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-75.
37. Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-13.
38. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
39. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2004;41:48-54.